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bilitation (group 1) or standard care (group 2). Postoperative follow up 
and rehabilitation in group 1 included clinical evaluation, chest X-ray, 
CT of thorax, bronchoscopy, and EBUS (Endobronchial Ultrasound) 
each year the following 5 years. Furthermore, the patients in group 1 
consulted a nurse and a physiotherapist, 6 weeks and 6 months after 
surgery. Patients in group 2 were only offered chest X-ray one year 
after surgery and a clinical examination by their community doctors, if 
they experienced any symptoms. 
Quality of life in both groups was assessed after 6 weeks, 6 months, 
12 months and 2 years by a standardized QOL-questionnaire (EORTC 
QLQ-C30). The 15 different scales in the QOL-questionnaire evaluate 
both functional status and symptoms.
Results: We found a signiﬁcant improvement of role functioning in 
favour of intensive follow-up and rehabilitation (p<0.01) There was 
also a signiﬁcant reduction of pain (p<0.01), fatigue (p<0.01), and loss 
of appetite (p<0.02) in this group.
Overall there was a tendency toward fewer symptoms and better func-
tional status in group 1 with intensive clinical follow-up and rehabilita-
tion compared to group 2.
Conclusion: The preliminary results of this randomized trial indicate 
that intensive follow-up and rehabilitation programmes for patients 
operated for non-small cell lung cancer increases functional status and 
reduces postoperative symptoms.
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Background: Accurate intraoperative diagnosis of lymph node metas-
tasis for patients with non-small cell lung cancer may facilitate decision 
of the extent of lymph node dissection at the time of surgery. The 
aim of this retrospective study was to deﬁne the accuracy of intraopera-
tive diagnosis of lymph node metastasis.
Methods: During the 14-year period between 1993 and 2006, 420 pa-
tients who underwent complete resection and mediastinal lymph node 
dissection for non-small cell lung cancer were reviewed in this study. 
Intraoperative diagnosis was made by individual surgeons using lymph 
node manipulation and/or frozen pathological examination.
Results: Of 420 patients, 
274 were men and 146 were 
women. Postoerative histologi-
cal diagnosis was as follows: 
adenocarcinoma, 259; squa-
mous cell carcinoma, 123; large 
cell carcinoma, 26; the other 
histological type, 11. Surgi-
cal diagnosis of lymph node 
metastasis was as follows: sN0, 
289; sN1, 50; sN2, 69; sN3, 12. 
Pathological diagnosis of lymph node metastasis was as follows: pN0, 
255; pN1, 56; pN2, 96; pN3, 13. The relationship between surgical 
(intraoperative) diagnosis and ﬁnal pathological diagnosis is shown in 
table. Of 289 patients who were recognized to have no lymph node me-
tastasis (sN0) during surgery, 28 (10%) patients had mediastinal lymph 
node metastasis (pN2) pathologically. Of 50 who were recognized to 
have hiler lymph node metastasis (sN1), 16 (32%) had mediastinal 
lymph node metastasis (pN2) pathologically. Whereas of 69 patients 
who were recognized to have mediastinal lymph node metastasis, 12 
(17%) patients had no lymph node metastasis (pN0). 
Conclusions: Surgical diagnosis for lymph node metastasis was inac-
curate. Systematic lymphadenectomy was recommended regardless of 
intraoperative diagnosis.
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Background: We evaluated the radiologic, pathologic and biologi-
cal aspects of lung cancers 3cm or smaller in diameter to predict their 
oncological behaviors.
Materials and Methods: We retrospectively reviewed CT, PET and 
pathology reports of 135 lung cancers smaller than 3cm among 302 
surgically resected lung cancers from June 2003 to May 2006. The 
ground-glass opacity(GGO) component of the tumor on HRCT, stan-
dardized uptake value(SUV) on FDG-PET, serum CEA, histopatho-
logic features and a panel of immunohistochemical stains including 
Glut-1, Ki-67, p16, p27 were evaluated.
Results: On HRCT, 32(23.7%) patients had GGO component; 14 were 
pure GGO and 18 were mixed GGO. Forty seven(34.8%) patients had 
lymph node metastasis; N1 in 28 cases, N2 in 19 cases. All N2 patients 
showed solid lesion except one mixed GGO with solid component 
more than 90%. During follow up period(mean=21months), all the 
recurred cases (n=15) had pure solid lesion. The maxSUV was a pre-
dictor of recurrence (p=0.03). The maxSUV of tumor was signiﬁcantly 
increased in soli d lesions (4.74) comparing pure(1.78) and mixed 
(1.41) GGO lesions. The maxSUV is signiﬁcantly low er in N0 tumors 
than N1 or N2 cases(p=0.04). The max SUV was also signiﬁcantly 
lower in BAC than in squamous cell carcinoma or large cell carcinoma 
(2.2 vs 5.7 or 8.8, p=0.04). Tumors with high maxSUV showed Glut-1 
and Ki-67 over-expression indicating increased cell proliferation. In 
contrast, tumors with GGO showed signiﬁcantly low maxSUV, low 
Glut-1 and Ki-67 expression and relatively maintained p16, p27 protein 
expression(p<0.05). Serum CEA level is higher in solid tumors(3.18ng/
ml vs 1.9 in GGO) and N2 lesions(5.07ng/ml vs 2.32 in N0 or 3.02 in 
N1, p=0.01), but had no correlation with recurrence. 
Conclusions: Showing good correlation with histopathologic panels 
and recurrence, GGO components and SUV could effectively utilized 
for the expectation of oncologic behaviors of the tumors and individu-
alized adjuvant therapy. 
